These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21910250)

  • 21. Asymmetric Cancer Hallmarks in Breast Tumors on Different Sides of the Body.
    Campoy EM; Laurito SR; Branham MT; Urrutia G; Mathison A; Gago F; Orozco J; Urrutia R; Mayorga LS; Roqué M
    PLoS One; 2016; 11(7):e0157416. PubMed ID: 27383829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
    Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
    Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
    Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
    Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methylation profiles capturing breast cancer heterogeneity.
    Chen X; Zhang J; Dai X
    BMC Genomics; 2019 Nov; 20(1):823. PubMed ID: 31699026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stromal-associated cytokines bias the interplay between gene expression and DNA methylation in human breast cancers.
    Hernandez-Vargas H; Goldsmith C; Mathot P; Dante R
    Epigenetics; 2020 May; 15(5):511-523. PubMed ID: 31838945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.
    Győrffy B; Bottai G; Fleischer T; Munkácsy G; Budczies J; Paladini L; Børresen-Dale AL; Kristensen VN; Santarpia L
    Int J Cancer; 2016 Jan; 138(1):87-97. PubMed ID: 26174627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
    Poli E; Zhang J; Nwachukwu C; Zheng Y; Adedokun B; Olopade OI; Han YJ
    PLoS One; 2015; 10(11):e0142224. PubMed ID: 26539832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A seven-gene CpG-island methylation panel predicts breast cancer progression.
    Li Y; Melnikov AA; Levenson V; Guerra E; Simeone P; Alberti S; Deng Y
    BMC Cancer; 2015 May; 15():417. PubMed ID: 25986046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of unanimous immune subtypes for different hormone receptor phenotypes of human breast cancer with potential prognostic significance.
    Yu C; Zhou L; Zhang Q
    Int Immunopharmacol; 2021 May; 94():107473. PubMed ID: 33611062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer.
    Lawrence MG; Pidsley R; Niranjan B; Papargiris M; Pereira BA; Richards M; Teng L; Norden S; Ryan A; Frydenberg M; Stirzaker C; Taylor RA; Risbridger GP; Clark SJ
    Clin Epigenetics; 2020 Mar; 12(1):48. PubMed ID: 32188493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying Methylation Pattern and Genes Associated with Breast Cancer Subtypes.
    Chen L; Zeng T; Pan X; Zhang YH; Huang T; Cai YD
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clofarabine, a novel adenosine analogue, reactivates DNA methylation-silenced tumour suppressor genes and inhibits cell growth in breast cancer cells.
    Lubecka-Pietruszewska K; Kaufman-Szymczyk A; Stefanska B; Cebula-Obrzut B; Smolewski P; Fabianowska-Majewska K
    Eur J Pharmacol; 2014 Jan; 723():276-87. PubMed ID: 24296317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation profiling of non-small cell lung cancer reveals a COPD-driven immune-related signature.
    Wauters E; Janssens W; Vansteenkiste J; Decaluwé H; Heulens N; Thienpont B; Zhao H; Smeets D; Sagaert X; Coolen J; Decramer M; Liston A; De Leyn P; Moisse M; Lambrechts D
    Thorax; 2015 Dec; 70(12):1113-22. PubMed ID: 26349763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status.
    Flanagan JM; Cocciardi S; Waddell N; Johnstone CN; Marsh A; Henderson S; Simpson P; da Silva L; ; Khanna K; Lakhani S; Boshoff C; Chenevix-Trench G
    Am J Hum Genet; 2010 Mar; 86(3):420-33. PubMed ID: 20206335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.
    Putnik M; Zhao C; Gustafsson JÅ; Dahlman-Wright K
    Biochem Biophys Res Commun; 2012 Sep; 426(1):26-32. PubMed ID: 22902638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normal breast tissue DNA methylation differences at regulatory elements are associated with the cancer risk factor age.
    Johnson KC; Houseman EA; King JE; Christensen BC
    Breast Cancer Res; 2017 Jul; 19(1):81. PubMed ID: 28693600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated analysis of gene expression and methylation profiles of 48 candidate genes in breast cancer patients.
    Li Z; Heng J; Yan J; Guo X; Tang L; Chen M; Peng L; Wu Y; Wang S; Xiao Z; Deng Z; Dai L; Wang J
    Breast Cancer Res Treat; 2016 Nov; 160(2):371-383. PubMed ID: 27722841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes.
    Li Y; Li S; Chen J; Shao T; Jiang C; Wang Y; Chen H; Xu J; Li X
    Hum Mol Genet; 2014 Oct; 23(20):5378-93. PubMed ID: 24871326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response.
    Dejeux E; Rønneberg JA; Solvang H; Bukholm I; Geisler S; Aas T; Gut IG; Børresen-Dale AL; Lønning PE; Kristensen VN; Tost J
    Mol Cancer; 2010 Mar; 9():68. PubMed ID: 20338046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.